Thermo Fisher Scientific Inc

Healthcare · Diagnostics & Research

675.00$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 44,557 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TMO
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2,933	3,558	3,868	2,471	2,281	2,188	2,086	2,097	2,206	2,633	3,792	9,746	10,498	10,110	10,789	11,726	12,510	13,090	16,890	16,965	18,274	20,918	24,358	25,542	32,218	39,211	44,915	42,857	42,879	44,557
Cost of Revenue	1,543	1,838	2,025	1,265	1,259	1,230	1,159	1,149	1,190	1,396	2,105	5,852	6,256	6,039	6,118	6,692	7,096	7,465	9,004	9,127	9,692	11,239	13,370	14,198	16,191	19,577	25,904	25,295	25,151	26,318
Gross Profit	1,390	1,721	1,843	1,206	1,022	959	927	948	1,016	1,237	1,687	3,894	4,242	4,070	4,275	4,867	5,414	5,626	7,886	7,838	8,582	9,679	10,988	11,344	16,027	19,634	19,011	17,562	17,728	18,239
Research & Development	301	337	367	171	177	172	155	146	135	153	170	239	249	246	284	340	376	396	691	692	755	888	967	1,003	1,181	1,406	1,471	1,337	1,390	1,397
Selling, General & Administrative	689	841	938	673	647	620	565	568	626	762	1,110	2,549	2,692	2,669	2,826	3,127	3,355	3,446	4,896	4,612	4,976	5,492	6,057	6,144	6,930	6,842	7,127	8,612	8,595	7,272
Total Operating Expenses	1,106	1,314	1,467	958	824	792	720	715	761	944	1,322	2,828	2,976	2,952	3,010	3,385	3,785	3,827	5,537	5,344	5,723	6,412	7,116	7,085	8,130	9,316	10,486	10,703	10,066	10,129
Operating Income	284	407	376	249	198	34	155	185	254	294	365	1,066	1,266	1,118	1,265	1,481	1,629	1,799	2,348	2,495	2,859	3,267	3,872	4,259	7,897	10,318	8,525	6,859	7,662	8,109
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11	27	52	140	130	118	85	192	242	262	480	415	470	592	667	676	553	536	726	1,375	1,654	1,419
Pre-Tax Income	302	414	348	19	174	77	288	219	259	286	209	881	1,150	927	1,088	1,133	1,269	1,320	2,087	1,936	2,024	2,429	3,262	4,070	7,227	8,837	7,663	6,298	6,995	7,267
Income Tax Expense	111	175	171	33	112	27	93	46	41	88	43	102	161	76	102	109	11	40	192	-44	-1.4	201	324	374	850	1,109	703	-284	657	547
Net Income	191	239	182	-175	-36	-0.8	310	200	362	223	169	761	994	850	1,036	1,330	1,178	1,273	1,894	1,975	2,022	2,225	2,938	3,696	6,375	7,725	6,950	5,995	6,335	6,737
EBITDA	399	372	353	362	296	265	193	279	336	436	502	1,778	2,072	1,833	1,912	2,184	2,495	2,582	4,252	4,040	4,252	5,054	6,195	7,023	10,108	11,969	11,942	6,859	11,800	11,466

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings